Hello, everyone, and how are you today? Another busy morning is unfolding here on the Pharmalot corporate campus, where we are, as usual, scurrying to deposit the short people at their respective houses of learning. Somehow, we always manage to do so on time. We have to attribute this feat to those cups of stimulation that show up here regularly. Perhaps you would like one yourself. While you indulge, here are some items of interest to start the day. Hope things go well and you conquer the world. Stay in touch...
Pfizer Criticizes India's Intellectual Property Policies (Reuters)
Maine Wants Mail Order Pharmacy To Resume Shipments (Portland Press-Herald)
J&J Exec Says Hip Implant Was Recalled For Clinical Reasons (Bloomberg News)
Animal-Rights Activists Protest AstraZeneca Beagle Testing (Wilmslow Express)
FDA OKs Imaging Drug For Lymph Nodes (USA Today)
Boehringer Signs Hepatitis C Drug Pact With Presidio (Pharma Times)
Wegman's Extends Free Offer Of Generic Lipitor (Philadelphia Inquirer)
Asthma Drug Pitched as Injectable Liposuction Alternative (Xconomy)
EDITOR'S NOTE: Please check this post for additional stories during the day